# US 2003/0212259 A1 · Recombinant photoproteins and their conjugates

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0212259 A1
- Document ID: US20030212259A1
- Status: Published application
- Kind: A1
- Application number: 10/400,630
- Filed: 2003-03-28
- Published: 2003-11-13
- Earliest claimed: 2002-03-29
- Assignees: Chisso Corporation
- Inventors: Satoshi Inouye
- Web page: https://patentgrep.com/patent/US20030212259A1

## CPC

- C07K 14/43595: {from coelenteratae, e.g. medusae}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

This invention is to provide a photoprotein which binds with a ligand specific for a substance to be detected at a binding ratio of 1:1 such that the luminescence activity is not reduced by binding with the ligand, a conjugate comprising the luminescent photoprotein and ligand, and a substance detection method which employs the conjugate as a marker. A calcium-binding photoprotein is produced having cysteine residue introduced within the 4th amino acid residue from the amino-terminus. A conjugate is formed by binding a ligand specific for a substance to be detected to the calcium-binding photoprotein, in a binding ratio of 1:1, via the introduced cysteine residue. The conjugate may be utilized as a marker for a substance to be detected.

## Claims

### Claim 1

A recombinant calcium-binding photoprotein comprising a wild-type or mutant apoprotein having one cysteine residue introduced within the 4th amino acid residue from the amino terminus of the wild-type apoprotein.

### Claim 2 (depends on 1)

The recombinant calcium-binding photoprotein according to claim 1, wherein the calcium-binding photoprotein is selected from the group consisting of aequorin, obelin, clytin, mitrocomin, mnemiopsin and berovin.

### Claim 3 (depends on 1)

The recombinant calcium-binding photoprotein according to claim 1, comprising as luminescent substrate coelenterazine or its analog which exhibits the luminescence activity.

### Claim 4 (depends on 1)

The recombinant calcium-binding photoprotein according to any one of claim 1, comprising an apoprotein having one cysteine residue introduced within the 4th amino acid residue from the amino terminus of the amino acid sequence of wild-type apoprotein listed as SEQ. ID. No.1 or its mutant apoprotein.

### Claim 5 (depends on 4)

The recombinant calcium-binding photo protein according to claim 4, comprising an apoprotein having the amino acid sequence listed as SEQ. ID. No.2, or an apoprotein having the amino acid sequence listed as SEQ. ID. No.2 modified by a deletion, substitution or addition of 1 to 5 amino acids such that the 6th cysteine is conserved and the luminescence activity is maintained.

### Claim 6

DNA coding for an apoprotein having one cysteine residue introduced within the 4th amino acid residue from the amino terminus of the amino acid sequence of wild-type apoprotein listed as SEQ. ID. No.1 or its mutant apoprotein.

### Claim 7 (depends on 6)

DNA according to claim 6, coding for an apoprotein having the amino acid sequence listed as SEQ. ID. No.2, or an apoprotein having the amino acid sequence listed as SEQ. ID. No.2 modified by a deletion, substitution or addition of 1 to 5 amino acids such that the 6th cysteine is conserved and the luminescence activity is maintained.

### Claim 8 (depends on 6)

An expression vector comprising DNA according to claim 6.

### Claim 9 (depends on 6)

Host cells transformed with an expression vector comprising DNA according to claim 6.

### Claim 10

A conjugate wherein a ligand specific for a substance to be detected binds to a recombinant calcium-binding photoprotein comprising a wild-type or mutant apoprotein having one cysteine residue introduced within the 4th amino acid residue from the amino terminus of the wild-type apoprotein, via said cysteine residue, in a ratio of 1:1.

### Claim 11 (depends on 10)

The conjugate according to claim 10, wherein the ligand specific for a substance to be detected is biotin, avidin, streptavidin, an enzyme, a substrate, an antibody, an antigen, nucleic acid, a polysaccharide, a receptor or a compound capable of binding to any of these.

### Claim 12 (depends on 10)

The conjugate according to claim 10, wherein the calcium-binding photoprotein is selected from the group consisting of aequorin, obelin, clytin, mitrocomin, mnemiopsin and berovin.

### Claim 13 (depends on 10)

The conjugate according to claim 10, comprising as luminescent substrate coelenterazine or its analog which exhibit luminescence activity.

### Claim 14 (depends on 10)

The conjugate according to claim 10, wherein a ligand specific for a substance to be detected binds to a recombinant calcium-binding photoprotein comprising an apoprotein having one cysteine residue introduced within the 4th amino acid residue from the amino terminus of the amino acid sequence of wild-type apoprotein listed as SEQ. ID. No.1 or its mutant apoprotein, via the introduced cysteine residue, in a ratio of 1:1.

### Claim 15 (depends on 10)

The conjugate according to claim 10, wherein a ligand specific for a substance to be detected binds to a recombinant calcium-binding photoprotein comprising an apoprotein having the amino acid sequence listed as SEQ. ID. No.2, or an apoprotein having the amino acid sequence listed as SEQ. ID. No.2 modified by a deletion, substitution or addition of 1 to 5 amino acids such that the 6th cysteine is conserved and luminescence activity is maintained, via the 6th cysteine, in a ratio of 1:1.

### Claim 16 (depends on 10)

The conjugate according to claim 10, wherein the ligand specific for a substance to be detected is biotin.

### Claim 17

A method for producing a conjugate, which comprises producing by genetic engineering an apoprotein having one cysteine residue introduced within the 4th amino acid residue from the amino terminus of the amino acid sequence of wild-type apoprotein listed as SEQ. ID. No.1 or its mutant apoprotein, treating the apoprotein with coelenterazine in the presence of molecular oxygen to yield a recombinant calcium-binding photoprotein, and binding the photoprotein via the introduced cysteine residue to a ligand specific for a substance to be detected, in a ratio of 1:1.

### Claim 18 (depends on 17)

The method for producing a conjugate according to claim 17, which comprises producing by genetic engineering an apoprotein having the amino acid sequence listed as SEQ. ID. No.2 or an apoprotein having the amino acid sequence listed as SEQ. ID. No.2 modified by a deletion, substitution or addition of 1 to 5 amino acids such that the 6th cysteine is conserved and luminescence activity is maintained, treating the apoprotein with coelenterazine in the presence of oxygen to yield a recombinant calcium-binding photoprotein, and binding the photoprotein via the 6th cysteine to a ligand specific for a substance to be detected, in a ratio of 1:1.

### Claim 19 (depends on 17)

The method for producing a conjugate according to claim 17, wherein the ligand specific for a substance to be detected is biotin.

### Claim 20 (depends on 10)

A method for measuring a substance specific for a ligand, characterized by using a conjugate according to claim 10.

### Claim 21 (depends on 10)

A kit for measuring a substance specific for a ligand, characterized by comprising a conjugate according to claim 10.
